Biocardia (BCDA) had the highest return in 2007 by a US stock in the Biotechnology Industry, returning 369.7%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Biocardia (BCDA) | 2007 | 369.7% |
Opko Health (OPK) | 2007 | 227.59% |
Travere Therapeutics (TVTX) | 2007 | 166.67% |
Enveric Biosciences (ENVB) | 2007 | 144.12% |
Biomarin Pharmaceutical (BMRN) | 2007 | 114.16% |
Rigel Pharmaceuticals (RIGL) | 2007 | 112.82% |
Anavex Life Sciences (AVXL) | 2007 | 94.44% |
Sangamo Therapeutics (SGMO) | 2007 | 93.77% |
United Therapeutics (UTHR) | 2007 | 79.5% |
Incyte (INCY) | 2007 | 71.5% |
Galectin Therapeutics (GALT) | 2007 | 62.79% |
Anixa Biosciences (ANIX) | 2007 | 61.11% |
Capricor Therapeutics (CAPR) | 2007 | 57.14% |
Imunon (IMNN) | 2007 | 56.31% |
Lineage Cell Therapeutics (LCTX) | 2007 | 54.71% |
XOMA (XOMA) | 2007 | 54.09% |
CervoMed (CRVO) | 2007 | 50% |
Myriad Genetics (MYGN) | 2007 | 47.93% |
Ionis Pharmaceuticals (IONS) | 2007 | 42.28% |
Gilead Sciences (GILD) | 2007 | 40.96% |
Alnylam Pharmaceuticals (ALNY) | 2007 | 33.39% |
Sonnet Biotherapeutics (SONN) | 2007 | 29.41% |
Alterity Therapeutics (ATHE) | 2007 | 25.39% |
Lifecore Biomedical (LFCR) | 2007 | 25.23% |
PharmaCyte Biotech (PMCB) | 2007 | 25.14% |
